Invesco Ltd. Avadel Pharmaceuticals PLC Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.03 - $7.95 $1.94 Million - $3.07 Million	-385,892 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.02 - $8.98 $1.75 Million - $3.14 Million	-349,229 Reduced 47.51%	385,892 $1.95 Million
Q2 2020 Aug 14, 2020	BUY	$7.25 - $11.75 $15,290 - $24,780	2,109 Added 0.29%	735,121 $5.94 Million
Q1 2020 May 15, 2020	BUY	$4.06 - $10.64 $2.98 Million - $7.8 Million	733,012 New	733,012 $5.82 Million

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $702M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.